0001209191-16-117514.txt : 20160504 0001209191-16-117514.hdr.sgml : 20160504 20160504181540 ACCESSION NUMBER: 0001209191-16-117514 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140414 FILED AS OF DATE: 20160504 DATE AS OF CHANGE: 20160504 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BG Medicine, Inc. CENTRAL INDEX KEY: 0001407038 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 043506204 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 880 WINTER STREET STREET 2: SUITE 210 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 781-890-1199 MAIL ADDRESS: STREET 1: 880 WINTER STREET STREET 2: SUITE 210 CITY: WALTHAM STATE: MA ZIP: 02451 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Adourian Aram S. CENTRAL INDEX KEY: 0001506699 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33827 FILM NUMBER: 161620950 MAIL ADDRESS: STREET 1: C/O BG MEDICINE, INC. STREET 2: 610 LINCOLN STREET NORTH CITY: WALTHAM STATE: MA ZIP: 02451 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2014-04-14 0 0001407038 BG Medicine, Inc. BGMD 0001506699 Adourian Aram S. C/O BG MEDICINE, INC. 303 WYMAN STREET, SUITE 300 WALTHAM MA 02451 0 1 0 0 SVP & Chief Scientific Officer Common Stock 2014-04-14 4 M 0 12000 0.90 A 40036 D Stock Option (right to buy) 0.90 2014-04-14 4 M 0 12000 0.00 D 2014-04-15 Common Stock 12000 16036 D The reporting person paid cash for the exercise price. The share and exercise price figures in this report do not reflect the 1-for-4 reverse stock split of the issuer's common stock effected on July 8, 2015. All of the shares underlying this option were vested and the option expired on April 15, 2014. /s/ John P. Condon, Attorney-in-fact 2016-05-04